Gallstones and the risk of biliary tract cancer: a population-based study in China

We conducted a population-based study of 627 patients with biliary tract cancers (368 of gallbladder, 191 bile duct, and 68 ampulla of Vater), 1037 with biliary stones, and 959 healthy controls randomly selected from the Shanghai population, all personally interviewed. Gallstone status was based on...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of cancer Vol. 97; no. 11; pp. 1577 - 1582
Main Authors Hsing, A W, Gao, Y-T, Han, T-Q, Rashid, A, Sakoda, L C, Wang, B-S, Shen, M-C, Zhang, B-H, Niwa, S, Chen, J, Fraumeni, J F
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 03.12.2007
Nature Publishing Group
Subjects
Online AccessGet full text
ISSN0007-0920
1532-1827
DOI10.1038/sj.bjc.6604047

Cover

Loading…
Abstract We conducted a population-based study of 627 patients with biliary tract cancers (368 of gallbladder, 191 bile duct, and 68 ampulla of Vater), 1037 with biliary stones, and 959 healthy controls randomly selected from the Shanghai population, all personally interviewed. Gallstone status was based on information from self-reports, imaging procedures, surgical notes, and medical records. Among controls, a transabdominal ultrasound was performed to detect asymptomatic gallstones. Gallstones removed from cancer cases and gallstone patients were classified by size, weight, colour, pattern, and content of cholesterol, bilirubin, and bile acids. Of the cancer patients, 69% had gallstones compared with 23% of the population controls. Compared with subjects without gallstones, odds ratios associated with gallstones were 23.8 (95% confidence interval (CI), 17.0–33.4), 8.0 (95% CI 5.6–11.4), and 4.2 (95% CI 2.5–7.0) for cancers of the gallbladder, extrahepatic bile ducts, and ampulla of Vater, respectively, persisting when restricted to those with gallstones at least 10 years prior to cancer. Biliary cancer risks were higher among subjects with both gallstones and self-reported cholecystitis, particularly for gallbladder cancer (OR=34.3, 95% CI 19.9–59.2). Subjects with bile duct cancer were more likely to have pigment stones, and with gallbladder cancer to have cholesterol stones ( P <0.001). Gallstone weight in gallbladder cancer was significantly higher than in gallstone patients (4.9 vs 2.8 grams; P =0.001). We estimate that in Shanghai 80% (95% CI 75–84%), 59% (56–61%), and 41% (29–59%) of gallbladder, bile duct, and ampulla of Vater cancers, respectively, could be attributed to gallstones.
AbstractList We conducted a population-based study of 627 patients with biliary tract cancers (368 of gallbladder, 191 bile duct, and 68 ampulla of Vater), 1037 with biliary stones, and 959 healthy controls randomly selected from the Shanghai population, all personally interviewed. Gallstone status was based on information from self-reports, imaging procedures, surgical notes, and medical records. Among controls, a transabdominal ultrasound was performed to detect asymptomatic gallstones. Gallstones removed from cancer cases and gallstone patients were classified by size, weight, colour, pattern, and content of cholesterol, bilirubin, and bile acids. Of the cancer patients, 69% had gallstones compared with 23% of the population controls. Compared with subjects without gallstones, odds ratios associated with gallstones were 23.8 (95% confidence interval (CI), 17.0–33.4), 8.0 (95% CI 5.6–11.4), and 4.2 (95% CI 2.5–7.0) for cancers of the gallbladder, extrahepatic bile ducts, and ampulla of Vater, respectively, persisting when restricted to those with gallstones at least 10 years prior to cancer. Biliary cancer risks were higher among subjects with both gallstones and self-reported cholecystitis, particularly for gallbladder cancer (OR=34.3, 95% CI 19.9–59.2). Subjects with bile duct cancer were more likely to have pigment stones, and with gallbladder cancer to have cholesterol stones ( P <0.001). Gallstone weight in gallbladder cancer was significantly higher than in gallstone patients (4.9 vs 2.8 grams; P =0.001). We estimate that in Shanghai 80% (95% CI 75–84%), 59% (56–61%), and 41% (29–59%) of gallbladder, bile duct, and ampulla of Vater cancers, respectively, could be attributed to gallstones.
We conducted a population-based study of 627 patients with biliary tract cancers (368 of gallbladder, 191 bile duct, and 68 ampulla of Vater), 1037 with biliary stones, and 959 healthy controls randomly selected from the Shanghai population, all personally interviewed. Gallstone status was based on information from self-reports, imaging procedures, surgical notes, and medical records. Among controls, a transabdominal ultrasound was performed to detect asymptomatic gallstones. Gallstones removed from cancer cases and gallstone patients were classified by size, weight, colour, pattern, and content of cholesterol, bilirubin, and bile acids. Of the cancer patients, 69% had gallstones compared with 23% of the population controls. Compared with subjects without gallstones, odds ratios associated with gallstones were 23.8 (95% confidence interval (CI), 17.0-33.4), 8.0 (95% CI 5.6-11.4), and 4.2 (95% CI 2.5-7.0) for cancers of the gallbladder, extrahepatic bile ducts, and ampulla of Vater, respectively, persisting when restricted to those with gallstones at least 10 years prior to cancer. Biliary cancer risks were higher among subjects with both gallstones and self-reported cholecystitis, particularly for gallbladder cancer (OR=34.3, 95% CI 19.9-59.2). Subjects with bile duct cancer were more likely to have pigment stones, and with gallbladder cancer to have cholesterol stones (P<0.001). Gallstone weight in gallbladder cancer was significantly higher than in gallstone patients (4.9 vs 2.8 grams; P=0.001). We estimate that in Shanghai 80% (95% CI 75-84%), 59% (56-61%), and 41% (29-59%) of gallbladder, bile duct, and ampulla of Vater cancers, respectively, could be attributed to gallstones.We conducted a population-based study of 627 patients with biliary tract cancers (368 of gallbladder, 191 bile duct, and 68 ampulla of Vater), 1037 with biliary stones, and 959 healthy controls randomly selected from the Shanghai population, all personally interviewed. Gallstone status was based on information from self-reports, imaging procedures, surgical notes, and medical records. Among controls, a transabdominal ultrasound was performed to detect asymptomatic gallstones. Gallstones removed from cancer cases and gallstone patients were classified by size, weight, colour, pattern, and content of cholesterol, bilirubin, and bile acids. Of the cancer patients, 69% had gallstones compared with 23% of the population controls. Compared with subjects without gallstones, odds ratios associated with gallstones were 23.8 (95% confidence interval (CI), 17.0-33.4), 8.0 (95% CI 5.6-11.4), and 4.2 (95% CI 2.5-7.0) for cancers of the gallbladder, extrahepatic bile ducts, and ampulla of Vater, respectively, persisting when restricted to those with gallstones at least 10 years prior to cancer. Biliary cancer risks were higher among subjects with both gallstones and self-reported cholecystitis, particularly for gallbladder cancer (OR=34.3, 95% CI 19.9-59.2). Subjects with bile duct cancer were more likely to have pigment stones, and with gallbladder cancer to have cholesterol stones (P<0.001). Gallstone weight in gallbladder cancer was significantly higher than in gallstone patients (4.9 vs 2.8 grams; P=0.001). We estimate that in Shanghai 80% (95% CI 75-84%), 59% (56-61%), and 41% (29-59%) of gallbladder, bile duct, and ampulla of Vater cancers, respectively, could be attributed to gallstones.
We conducted a population-based study of 627 patients with biliary tract cancers (368 of gallbladder, 191 bile duct, and 68 ampulla of Vater), 1037 with biliary stones, and 959 healthy controls randomly selected from the Shanghai population, all personally interviewed. Gallstone status was based on information from self-reports, imaging procedures, surgical notes, and medical records. Among controls, a transabdominal ultrasound was performed to detect asymptomatic gallstones. Gallstones removed from cancer cases and gallstone patients were classified by size, weight, colour, pattern, and content of cholesterol, bilirubin, and bile acids. Of the cancer patients, 69% had gallstones compared with 23% of the population controls. Compared with subjects without gallstones, odds ratios associated with gallstones were 23.8 (95% confidence interval (CI), 17.0-33.4), 8.0 (95% CI 5.6-11.4), and 4.2 (95% CI 2.5-7.0) for cancers of the gallbladder, extrahepatic bile ducts, and ampulla of Vater, respectively, persisting when restricted to those with gallstones at least 10 years prior to cancer. Biliary cancer risks were higher among subjects with both gallstones and self-reported cholecystitis, particularly for gallbladder cancer (OR = 34.3, 95% CI 19.9-59.2). Subjects with bile duct cancer were more likely to have pigment stones, and with gallbladder cancer to have cholesterol stones (P < 0.001). Gallstone weight in gallbladder cancer was significantly higher than in gallstone patients (4.9 vs 2.8 grams; P = 0.001). We estimate that in Shanghai 80% (95% CI 75-84%), 59% (56-61%), and 41% (29-59%) of gallbladder, bile duct, and ampulla of Vater cancers, respectively, could be attributed to gallstones.
Author Hsing, A W
Zhang, B-H
Shen, M-C
Gao, Y-T
Chen, J
Niwa, S
Rashid, A
Sakoda, L C
Han, T-Q
Wang, B-S
Fraumeni, J F
Author_xml – sequence: 1
  givenname: A W
  surname: Hsing
  fullname: Hsing, A W
  email: hsinga@mail.nih.gov
  organization: Division of Cancer Epidemiology and Genetics, National Cancer Institute
– sequence: 2
  givenname: Y-T
  surname: Gao
  fullname: Gao, Y-T
  organization: Shanghai Cancer Institute
– sequence: 3
  givenname: T-Q
  surname: Han
  fullname: Han, T-Q
  organization: Ruijin Hospital, Shanghai Second Medical University
– sequence: 4
  givenname: A
  surname: Rashid
  fullname: Rashid, A
  organization: Department of Pathology, University of Texas MD Anderson Cancer Center
– sequence: 5
  givenname: L C
  surname: Sakoda
  fullname: Sakoda, L C
  organization: Department of Epidemiology, University of Washington, Seattle, WA 98195
– sequence: 6
  givenname: B-S
  surname: Wang
  fullname: Wang, B-S
  organization: Zhongshan Hospital, Fudan University
– sequence: 7
  givenname: M-C
  surname: Shen
  fullname: Shen, M-C
  organization: Shanghai Tumor Hospital
– sequence: 8
  givenname: B-H
  surname: Zhang
  fullname: Zhang, B-H
  organization: Institute of Oriental Hepatobiliary Surgery, Second Military Medical University
– sequence: 9
  givenname: S
  surname: Niwa
  fullname: Niwa, S
  organization: Westat Inc
– sequence: 10
  givenname: J
  surname: Chen
  fullname: Chen, J
  organization: University of Pennsylvania
– sequence: 11
  givenname: J F
  surname: Fraumeni
  fullname: Fraumeni, J F
  organization: Division of Cancer Epidemiology and Genetics, National Cancer Institute
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19977624$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/18000509$$D View this record in MEDLINE/PubMed
BookMark eNqFkt9rFDEQx4NU7LX66qMEwb7tdZLd_FgfBDlqFQqC6HPIJtlezlxyJrtC_3ujd3paKD6EZMjn-81kZs7QSUzRIfScwJJAKy_LZjlszJJz6KATj9CCsJY2RFJxghYAIBroKZyis1I2NexBiifolMh6ZtAv0KdrHUKZqmnBOlo8rR3OvnzFacSDD17nOzxlbSZsdDQuv8Ya79JuDnryKTaDLs7iMs32DvuIV2sf9VP0eNShuGeH_Rx9eXf1efW-ufl4_WH19qYxTNKpYYz3sucjEZppYyl30upxZLodZF3WciADtYYKxztrWCdrBNCCc1KQnrTn6M3edzcPW2eNizXRoHbZb2vWKmmv_r2Jfq1u03dFWw6UiWpwcTDI6dvsyqS2vhgXgo4uzUVxyTrBWvlfkAIjHNq2gi_vgZs051irUB8FoJwTWqEXf-f9J-HfTanAqwOgi9FhzLXyvhy5vheC065yyz1nciolu_GIgPo5HapsVJ0OdZiOKujuCYyffjWy1seHh2WXe1mp_vHW5eOvHlD8ACGLzng
CODEN BJCAAI
CitedBy_id crossref_primary_10_3390_nu9090950
crossref_primary_10_1007_s10654_015_0081_y
crossref_primary_10_1016_j_jhep_2020_11_033
crossref_primary_10_5301_tj_5000397
crossref_primary_10_1111_eci_12185
crossref_primary_10_1016_j_cgh_2017_11_034
crossref_primary_10_1016_S1499_3872_13_60030_2
crossref_primary_10_1097_MD_0000000000022292
crossref_primary_10_1186_1750_9378_6_6
crossref_primary_10_4251_wjgo_v12_i12_1381
crossref_primary_10_1016_S0221_0363_10_70032_9
crossref_primary_10_23736_S0394_9508_21_05327_4
crossref_primary_10_1007_s11377_017_0216_7
crossref_primary_10_1097_CM9_0000000000002258
crossref_primary_10_15388_LietChirur_2024_23_2__3
crossref_primary_10_1007_s12029_019_00347_1
crossref_primary_10_1007_s12029_011_9284_y
crossref_primary_10_1093_carcin_bgq194
crossref_primary_10_1007_s11523_024_01086_5
crossref_primary_10_1158_1055_9965_EPI_07_2704
crossref_primary_10_1016_j_canlet_2021_09_004
crossref_primary_10_7314_APJCP_2015_16_7_2923
crossref_primary_10_1038_s41416_022_01877_5
crossref_primary_10_1186_s12885_022_09382_x
crossref_primary_10_1038_sj_bjc_6604616
crossref_primary_10_1186_s12014_023_09399_9
crossref_primary_10_9738_INTSURG_D_18_00013_1
crossref_primary_10_1155_2023_8104679
crossref_primary_10_1186_1756_9966_30_2
crossref_primary_10_1136_gutjnl_2018_317504
crossref_primary_10_5009_gnl_2012_6_2_172
crossref_primary_10_4143_crt_2017_279
crossref_primary_10_1016_j_mrrev_2011_06_002
crossref_primary_10_1038_sj_bjc_6605706
crossref_primary_10_1007_s13193_012_0150_6
crossref_primary_10_4178_epih_e2021011
crossref_primary_10_1093_jnci_djz103
crossref_primary_10_3390_cancers13051186
crossref_primary_10_1111_jgh_14054
crossref_primary_10_1038_bjc_2011_363
crossref_primary_10_1111_jgh_12278
crossref_primary_10_1002_dc_21821
crossref_primary_10_1002_hep_30861
crossref_primary_10_1158_1055_9965_EPI_20_0919
crossref_primary_10_1016_j_jfma_2024_09_010
crossref_primary_10_1016_j_suronc_2010_09_003
crossref_primary_10_1371_journal_pone_0070265
crossref_primary_10_7314_APJCP_2015_16_14_5647
crossref_primary_10_1016_j_ejso_2020_03_222
crossref_primary_10_1158_1055_9965_EPI_07_2735
crossref_primary_10_1016_j_suc_2014_01_009
crossref_primary_10_1016_j_gcb_2008_09_009
crossref_primary_10_1186_s12876_020_01312_0
crossref_primary_10_31146_1682_8658_ecg_205_9_153_160
crossref_primary_10_1016_j_cyto_2016_05_003
crossref_primary_10_1016_j_cyto_2015_01_033
crossref_primary_10_3390_medicina61030452
crossref_primary_10_1007_s00423_015_1300_4
crossref_primary_10_1007_s11864_013_0237_5
crossref_primary_10_1080_0284186X_2018_1549367
crossref_primary_10_1155_2019_1389289
crossref_primary_10_18231_j_jdpo_2020_070
crossref_primary_10_3748_wjg_v21_i12_3679
crossref_primary_10_1002_ijc_34794
crossref_primary_10_1016_S0716_8640_11_70454_0
crossref_primary_10_3390_ijerph192416625
crossref_primary_10_3390_cancers15153880
crossref_primary_10_1186_s12944_025_02472_2
crossref_primary_10_1371_journal_pone_0173935
crossref_primary_10_1002_ijc_23307
crossref_primary_10_1093_carcin_bgp024
crossref_primary_10_1097_HEP_0000000000000748
crossref_primary_10_1186_s12885_015_1870_0
crossref_primary_10_1002_mc_20641
crossref_primary_10_1111_j_1365_2559_2008_03192_x
crossref_primary_10_15279_kpba_2022_27_3_121
crossref_primary_10_1111_hel_12457
crossref_primary_10_1038_srep18160
crossref_primary_10_1111_cbdd_12533
crossref_primary_10_1371_journal_pone_0069981
crossref_primary_10_1016_j_canep_2018_03_004
crossref_primary_10_3390_biom14060676
crossref_primary_10_1186_s12944_021_01523_8
crossref_primary_10_1002_ijc_28161
crossref_primary_10_1186_1471_2407_12_468
crossref_primary_10_1177_147323000903700429
crossref_primary_10_1186_1756_9966_28_65
crossref_primary_10_1016_j_yexmp_2011_06_004
crossref_primary_10_3389_fphys_2022_888233
crossref_primary_10_1002_jssc_201400638
crossref_primary_10_1016_j_ejso_2010_05_002
crossref_primary_10_1007_s13193_012_0203_x
crossref_primary_10_1097_CM9_0000000000003395
crossref_primary_10_1016_j_humpath_2024_07_001
crossref_primary_10_18632_oncotarget_3861
crossref_primary_10_3390_cancers14133093
crossref_primary_10_1038_sj_bjc_6605597
crossref_primary_10_1002_ijc_32952
crossref_primary_10_1016_j_humpath_2010_12_026
crossref_primary_10_1136_gutjnl_2024_333368
crossref_primary_10_1007_s12253_013_9660_y
crossref_primary_10_3390_jpm12020234
crossref_primary_10_1007_s10552_011_9802_z
crossref_primary_10_1016_j_jdiacomp_2015_11_012
crossref_primary_10_1053_j_gastro_2017_04_005
crossref_primary_10_1093_aje_kwt322
crossref_primary_10_1038_s41572_022_00398_y
crossref_primary_10_1371_journal_pone_0016449
crossref_primary_10_1111_jgh_15759
crossref_primary_10_1007_s13193_021_01480_9
crossref_primary_10_18410_jebmh_2017_1166
crossref_primary_10_1016_j_jpha_2023_06_003
crossref_primary_10_1111_jgh_14265
crossref_primary_10_7759_cureus_28260
crossref_primary_10_1007_s10147_013_0550_9
crossref_primary_10_1080_09637480902970967
crossref_primary_10_7314_APJCP_2013_14_4_2185
crossref_primary_10_1093_carcin_bgq038
crossref_primary_10_3389_fonc_2022_1046974
crossref_primary_10_1007_s13193_021_01455_w
crossref_primary_10_1111_j_1478_3231_2009_02149_x
crossref_primary_10_1007_s12262_019_02050_8
crossref_primary_10_1016_j_canep_2018_06_004
crossref_primary_10_3390_cancers14051249
crossref_primary_10_1016_j_ijsu_2011_07_001
crossref_primary_10_1186_1477_7819_11_143
crossref_primary_10_1002_gcc_20928
crossref_primary_10_1016_j_mgene_2014_04_012
crossref_primary_10_1016_j_hpb_2019_11_012
crossref_primary_10_1111_ans_18577
crossref_primary_10_2147_IJGM_S297371
crossref_primary_10_3389_fonc_2020_00823
crossref_primary_10_1016_j_rcl_2014_02_011
crossref_primary_10_1016_j_ejca_2011_10_038
crossref_primary_10_3748_wjg_v27_i45_7813
crossref_primary_10_1371_journal_pone_0089368
crossref_primary_10_18632_oncotarget_14815
crossref_primary_10_1186_s12889_019_7160_z
crossref_primary_10_3390_cancers2031602
crossref_primary_10_1002_oby_21505
crossref_primary_10_15430_JCP_2020_25_3_164
crossref_primary_10_1177_1553350620950582
crossref_primary_10_12998_wjcc_v10_i29_10399
crossref_primary_10_3390_jpm11121261
crossref_primary_10_1016_j_plipres_2018_06_001
crossref_primary_10_4103_oji_oji_51_20
crossref_primary_10_1002_cbin_11804
crossref_primary_10_1002_hep_32198
crossref_primary_10_1136_gutjnl_2023_331773
crossref_primary_10_1158_0008_5472_CAN_08_0444
crossref_primary_10_1016_S1665_2681_19_31285_2
crossref_primary_10_4103_ijcm_ijcm_796_23
crossref_primary_10_1002_ijc_32863
crossref_primary_10_1186_s12885_020_07139_y
crossref_primary_10_46889_JSRP_2023_4305
crossref_primary_10_1007_s00535_012_0683_z
crossref_primary_10_1093_annonc_mdn533
crossref_primary_10_1016_j_canrad_2020_06_039
crossref_primary_10_1007_s40137_015_0122_1
crossref_primary_10_1111_j_1445_2197_2009_05033_x
crossref_primary_10_1038_s41598_018_23848_8
crossref_primary_10_1016_j_annepidem_2016_08_009
crossref_primary_10_1093_jscr_rjy166
crossref_primary_10_5009_gnl210009
crossref_primary_10_1186_s12876_024_03426_1
crossref_primary_10_4251_wjgo_v11_i3_238
crossref_primary_10_1016_j_soc_2019_06_012
crossref_primary_10_4143_crt_2016_538
crossref_primary_10_1016_j_dld_2010_06_005
crossref_primary_10_3348_jksr_2011_64_3_253
Cites_doi 10.2188/jea.15.S150
10.1016/0009-8981(75)90364-2
10.3322/canjclin.51.6.349
10.7326/0003-4819-107-1-30
10.1097/00000658-199104000-00006
10.1002/(SICI)1097-0215(19980130)75:3<368::AID-IJC7>3.0.CO;2-0
10.2741/A699
10.1002/1097-0142(19950101)75:1+<171::AID-CNCR2820751306>3.0.CO;2-2
10.1001/jama.1983.03340170049027
10.1093/carcin/bgi314
10.1046/j.1440-1622.2000.01926.x
10.1097/00008469-200508000-00011
10.1158/1078-0432.CCR-1137-3
10.1093/clinchem/35.1.173
10.3748/wjg.v4.i1.82
10.1093/jnci/89.15.1132
10.1002/bmc.1130040403
10.1158/1055-9965.EPI-05-0032
10.1093/acprof:oso/9780195149616.003.0040
10.7326/0003-4819-118-3-199302010-00005
10.1016/S0889-8553(21)00531-8
10.1002/1097-0142(19800301)45:5<919::AID-CNCR2820450514>3.0.CO;2-4
ContentType Journal Article
Copyright The Author(s) 2007
2008 INIST-CNRS
Copyright Nature Publishing Group Dec 3, 2007
Copyright © 2007 Cancer Research UK 2007 Cancer Research UK
Copyright_xml – notice: The Author(s) 2007
– notice: 2008 INIST-CNRS
– notice: Copyright Nature Publishing Group Dec 3, 2007
– notice: Copyright © 2007 Cancer Research UK 2007 Cancer Research UK
DBID C6C
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7TO
7U9
7X7
7XB
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AN0
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB0
LK8
M0S
M1P
M7P
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7U1
C1K
7X8
5PM
DOI 10.1038/sj.bjc.6604047
DatabaseName Springer Nature OA Free Journals
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
British Nursing Database
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Biological Science Database
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Risk Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Public Health
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
British Nursing Index with Full Text
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
Risk Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
Risk Abstracts

MEDLINE
ProQuest Central Student
Database_xml – sequence: 1
  dbid: C6C
  name: SpringerOpen Free (Free internet resource, activated by CARLI)
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Gallstones and the risk of biliary tract cancer
EISSN 1532-1827
EndPage 1582
ExternalDocumentID PMC2360257
1390227761
18000509
19977624
10_1038_sj_bjc_6604047
Genre Journal Article
Research Support, N.I.H., Intramural
GeographicLocations Asia
China
United States--US
China, People's Rep., Shanghai
China, People's Rep
GeographicLocations_xml – name: China
– name: United States--US
– name: China, People's Rep
– name: China, People's Rep., Shanghai
GrantInformation_xml – fundername: Intramural NIH HHS
GroupedDBID ---
-Q-
0R~
23N
36B
39C
3V.
4.4
406
53G
5GY
5RE
6J9
7RV
7X7
88E
8AO
8C1
8FI
8FJ
8R4
8R5
AANZL
AAWTL
AAYZH
AAZLF
ABAKF
ABAWZ
ABDBF
ABLJU
ABOCM
ABUWG
ABZZP
ACAOD
ACGFO
ACGFS
ACKTT
ACPRK
ACRQY
ACUHS
ACZOJ
ADBBV
ADFRT
ADHDB
AEFQL
AEJRE
AEMSY
AENEX
AEVLU
AFBBN
AFKRA
AFRAH
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AJRNO
ALFFA
ALMA_UNASSIGNED_HOLDINGS
AMYLF
AN0
AOIJS
ASPBG
AVWKF
AXYYD
AZFZN
B0M
BAWUL
BBNVY
BENPR
BHPHI
BKEYQ
BKKNO
BNQBC
BPHCQ
BVXVI
C6C
CAG
CCPQU
COF
CS3
DIK
DNIVK
DPUIP
DU5
E3Z
EAD
EAP
EAS
EBC
EBD
EBLON
EBS
EE.
EIOEI
EJD
EMB
EMK
EMOBN
EPL
ESX
EX3
F5P
FDQFY
FEDTE
FERAY
FIZPM
FRJ
FSGXE
FYUFA
GX1
HCIFZ
HMCUK
HVGLF
HYE
HZ~
IH2
IWAJR
J5H
JSO
JZLTJ
KQ8
M1P
M7P
NAO
NAPCQ
NQJWS
O9-
OK1
P2P
PQQKQ
PROAC
PSQYO
Q2X
RNT
RNTTT
ROL
RPM
SNX
SNYQT
SOHCF
SOJ
SRMVM
SV3
SWTZT
TAOOD
TBHMF
TDRGL
TR2
TUS
UKHRP
W2D
WH7
WOW
~02
~8M
AAFWJ
AASML
AAYXX
ABBRH
ABDBE
ABFSG
ACMFV
ACSTC
AEZWR
AFDZB
AFHIU
AHWEU
AIGIU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
.55
.GJ
70F
8WZ
A6W
AACDK
AATNV
ABRTQ
AEXYK
AI.
AILAN
FIGPU
IQODW
M41
PJZUB
PPXIY
PQGLB
UDS
VH1
X7M
Y6R
ZGI
CGR
CUY
CVF
ECM
EIF
NPM
7TO
7U9
7XB
8FE
8FH
8FK
AZQEC
DWQXO
GNUQQ
H94
K9.
LK8
PKEHL
PQEST
PQUKI
PRINS
7U1
C1K
7X8
5PM
ID FETCH-LOGICAL-c582t-5569896f17a5acd26e8daff5a3b8a3bdd601b2dc27e64dc548b2d0030ee871913
IEDL.DBID 7X7
ISSN 0007-0920
IngestDate Thu Aug 21 18:42:46 EDT 2025
Thu Jul 10 17:16:36 EDT 2025
Thu Jul 10 23:11:11 EDT 2025
Fri Jul 25 08:53:06 EDT 2025
Mon Jul 21 06:04:31 EDT 2025
Mon Jul 21 09:12:59 EDT 2025
Tue Jul 01 04:29:24 EDT 2025
Thu Apr 24 23:08:41 EDT 2025
Fri Feb 21 02:43:13 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords biliary tract cancer
cholecystitis
gallstones
China
Human
Digestive system
Bile duct cancer
Biliary tract disease
Epidemiology
Cholelithiasis
Cancerology
Risk factor
Digestive diseases
Gallbladder
Cholecystitis
Language English
License http://www.springer.com/tdm
CC BY 4.0
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c582t-5569896f17a5acd26e8daff5a3b8a3bdd601b2dc27e64dc548b2d0030ee871913
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
OpenAccessLink https://www.nature.com/articles/sj.bjc.6604047
PMID 18000509
PQID 230026612
PQPubID 41855
PageCount 6
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2360257
proquest_miscellaneous_68547538
proquest_miscellaneous_20516033
proquest_journals_230026612
pubmed_primary_18000509
pascalfrancis_primary_19977624
crossref_primary_10_1038_sj_bjc_6604047
crossref_citationtrail_10_1038_sj_bjc_6604047
springer_journals_10_1038_sj_bjc_6604047
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20071203
PublicationDateYYYYMMDD 2007-12-03
PublicationDate_xml – month: 12
  year: 2007
  text: 20071203
  day: 3
PublicationDecade 2000
PublicationPlace London
PublicationPlace_xml – name: London
– name: Basingstoke
– name: England
PublicationTitle British journal of cancer
PublicationTitleAbbrev Br J Cancer
PublicationTitleAlternate Br J Cancer
PublicationYear 2007
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References S Zou (BF6604047_CR31) 2000; 38
AW Hsing (BF6604047_CR12) 2006
J Albores-Saavedra (BF6604047_CR1) 1980; 45
A Maringhini (BF6604047_CR17) 1987; 107
LC Sakoda (BF6604047_CR23) 2006; 27
AK Diehl (BF6604047_CR4) 1983; 250
AW Hsing (BF6604047_CR11) 1998; 75
L Vitetta (BF6604047_CR26) 2000; 70
A Rashid (BF6604047_CR20) 2002; 8
A Swidsinski (BF6604047_CR24) 2001; 6
U Dutts Dutta (BF6604047_CR6) 2005; 14
W Wang (BF6604047_CR28) 2003; 24
E Liu (BF6604047_CR15) 2005; 14
T Ueki (BF6604047_CR25) 2004; 10
A el Zayadi (BF6604047_CR7) 1991; 38
YQ Huang (BF6604047_CR13) 1987; 25
X Zhu (BF6604047_CR30) 1995; 33
EC Lazcano-Ponce (BF6604047_CR14) 2001; 51
K Rothman (BF6604047_CR22) 1998
MT Carriaga (BF6604047_CR2) 1995; 75
TQ Han (BF6604047_CR10) 1998; 4
CH Grimaldi (BF6604047_CR9) 1993; 118
A Oda (BF6604047_CR19) 1975; 64
A Roda (BF6604047_CR21) 1975; 64
T Matsuba (BF6604047_CR18) 2005; 15
GF Wang (BF6604047_CR27) 1990; 4
WA Zatonski (BF6604047_CR29) 1997; 89
AB Lowenfels (BF6604047_CR16) 1985; 75
AK Diehl (BF6604047_CR5) 1991; 20
F Cetta (BF6604047_CR3) 1991; 213
P Fossati (BF6604047_CR8) 1989; 35
References_xml – volume: 15
  start-page: S150
  issue: Suppl 2
  year: 2005
  ident: BF6604047_CR18
  publication-title: J Epidemiol
  doi: 10.2188/jea.15.S150
– volume: 64
  start-page: 337
  year: 1975
  ident: BF6604047_CR21
  publication-title: Clin Chim Acta
  doi: 10.1016/0009-8981(75)90364-2
– volume: 51
  start-page: 349
  year: 2001
  ident: BF6604047_CR14
  publication-title: CA Cancer J Clin
  doi: 10.3322/canjclin.51.6.349
– volume: 75
  start-page: 77
  year: 1985
  ident: BF6604047_CR16
  publication-title: J Natl Cancer Inst
– volume: 8
  start-page: 3156
  year: 2002
  ident: BF6604047_CR20
  publication-title: Clin Cancer Res
– volume: 107
  start-page: 30
  year: 1987
  ident: BF6604047_CR17
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-107-1-30
– volume: 213
  start-page: 315
  year: 1991
  ident: BF6604047_CR3
  publication-title: Ann Surg
  doi: 10.1097/00000658-199104000-00006
– volume: 75
  start-page: 368
  year: 1998
  ident: BF6604047_CR11
  publication-title: Int J Cancer
  doi: 10.1002/(SICI)1097-0215(19980130)75:3<368::AID-IJC7>3.0.CO;2-0
– volume: 6
  start-page: E93
  year: 2001
  ident: BF6604047_CR24
  publication-title: Front Biosci
  doi: 10.2741/A699
– volume: 64
  start-page: 337
  year: 1975
  ident: BF6604047_CR19
  publication-title: Clin Chim Acta
  doi: 10.1016/0009-8981(75)90364-2
– volume: 75
  start-page: 171
  year: 1995
  ident: BF6604047_CR2
  publication-title: Cancer
  doi: 10.1002/1097-0142(19950101)75:1+<171::AID-CNCR2820751306>3.0.CO;2-2
– volume: 250
  start-page: 2323
  year: 1983
  ident: BF6604047_CR4
  publication-title: JAMA
  doi: 10.1001/jama.1983.03340170049027
– volume: 38
  start-page: 805
  year: 2000
  ident: BF6604047_CR31
  publication-title: Zhonghua Wai Ke Za Zhi
– volume: 27
  start-page: 1251
  year: 2006
  ident: BF6604047_CR23
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgi314
– volume: 70
  start-page: 667
  year: 2000
  ident: BF6604047_CR26
  publication-title: Aust NZ J Surg
  doi: 10.1046/j.1440-1622.2000.01926.x
– volume: 14
  start-page: 381
  year: 2005
  ident: BF6604047_CR6
  publication-title: Eur J Cancer Prev
  doi: 10.1097/00008469-200508000-00011
– volume: 24
  start-page: 272
  year: 2003
  ident: BF6604047_CR28
  publication-title: Zhonghua Liu Xing Bing Xue Za Zhi
– volume: 25
  start-page: 346
  year: 1987
  ident: BF6604047_CR13
  publication-title: Zhonghua Wai Ke Za Zhi
– volume: 10
  start-page: 1717
  year: 2004
  ident: BF6604047_CR25
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-1137-3
– volume: 35
  start-page: 173
  year: 1989
  ident: BF6604047_CR8
  publication-title: Clin Chem
  doi: 10.1093/clinchem/35.1.173
– volume: 4
  start-page: 82
  year: 1998
  ident: BF6604047_CR10
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v4.i1.82
– volume: 89
  start-page: 1132
  year: 1997
  ident: BF6604047_CR29
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/89.15.1132
– volume: 4
  start-page: 136
  year: 1990
  ident: BF6604047_CR27
  publication-title: Biomed Chromatogr
  doi: 10.1002/bmc.1130040403
– volume: 38
  start-page: 337
  year: 1991
  ident: BF6604047_CR7
  publication-title: Hepatogastroenterology
– volume: 14
  start-page: 1315
  year: 2005
  ident: BF6604047_CR15
  publication-title: Cancer Epidemiol Biomarkers Prev
  doi: 10.1158/1055-9965.EPI-05-0032
– start-page: 787
  volume-title: Cancer Epidemiology and Prevention
  year: 2006
  ident: BF6604047_CR12
  doi: 10.1093/acprof:oso/9780195149616.003.0040
– volume: 118
  start-page: 185
  year: 1993
  ident: BF6604047_CR9
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-118-3-199302010-00005
– volume-title: Modern Epidemiology
  year: 1998
  ident: BF6604047_CR22
– volume: 33
  start-page: 652
  year: 1995
  ident: BF6604047_CR30
  publication-title: Zhonghua Wai Ke Za Zhi
– volume: 20
  start-page: 1
  year: 1991
  ident: BF6604047_CR5
  publication-title: Gastroenterol Clin North Am
  doi: 10.1016/S0889-8553(21)00531-8
– volume: 45
  start-page: 919
  year: 1980
  ident: BF6604047_CR1
  publication-title: Cancer
  doi: 10.1002/1097-0142(19800301)45:5<919::AID-CNCR2820450514>3.0.CO;2-4
SSID ssj0009087
Score 2.3608308
Snippet We conducted a population-based study of 627 patients with biliary tract cancers (368 of gallbladder, 191 bile duct, and 68 ampulla of Vater), 1037 with...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1577
SubjectTerms Aged
Bile Acids and Salts - analysis
Bile ducts
Biliary Tract - chemistry
Biliary Tract - pathology
Biliary Tract Neoplasms - epidemiology
Bilirubin - analysis
Biological and medical sciences
Biomedical and Life Sciences
Biomedicine
Cancer Research
China - epidemiology
Cholangiocarcinoma
Cholesterol - analysis
Drug Resistance
Epidemiology
Female
Gallbladder cancer
Gallbladder diseases
Gallstones
Gallstones - metabolism
Gallstones - pathology
Gastroenterology. Liver. Pancreas. Abdomen
Hospitals
Humans
Liver. Biliary tract. Portal circulation. Exocrine pancreas
Male
Medical research
Medical sciences
Middle Aged
Molecular Medicine
Odds Ratio
Oncology
Organ Size
Other diseases. Semiology
Pathology
Population Surveillance - methods
Population-based studies
Risk Factors
Skin cancer
Tumors
SummonAdditionalLinks – databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LS-RAEC5WFxZBxH2o8dmHhd1LNNOddHe8yeCDBfewrOAt9CvsDEMcJuPBf29VHjOMq-Ahh9AV0qnqx1ddla8AvjvrbR4EDl4b0EFByBxriz5PUKmxPFdUKZOyLX7Lm7v013123zmKdZdW2VJaNst0nx12Vo9P7didSomDLlVr8JFo2ymFbyiHS5LdRLccmXT8lvOkJ2kU-sXzK5vQ5tTUqI-yLWTxGtL8P2HyRdS02YyutmGrQ5Hsou33Z_gQqi_w6baLk3-FP9dmMiFYF2pmKs8Q5TFKImcPJaNsWDN7YnP6P4o5svrsnBk2XZTyimlr86xhnmWjijU1tr_B3dXl3-FN3FVPiF2m-TzOMqoNKcuBMplxnsugvSnLzAir8fIeXTHLveMqyNQ79FzwjuZ8COhE5QOxA-sV9nMPmFT5oBw45xX3uLAKmwSjHbfK5IL4DCOIe3UWrqMWpwoXk6IJcQtd1OMC1V906o_gx0J-2pJqvCl5vGKdpXiOwFXyNIKD3lxFN_vqAt2qhIAHj-Bk0YrThmIhpgoPjyiCi5FMhHhbQuosRV9OR7DbGn_5bt3S5kSgVobFQoAou1dbqtG_hrqbC4kgEz_rZz-Alr1-XQP77xc9gI3m5JmSbcQhrM9nj-EIIdPcHjfz5BlRfxWT
  priority: 102
  providerName: Springer Nature
Title Gallstones and the risk of biliary tract cancer: a population-based study in China
URI https://link.springer.com/article/10.1038/sj.bjc.6604047
https://www.ncbi.nlm.nih.gov/pubmed/18000509
https://www.proquest.com/docview/230026612
https://www.proquest.com/docview/20516033
https://www.proquest.com/docview/68547538
https://pubmed.ncbi.nlm.nih.gov/PMC2360257
Volume 97
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEB-0BRFE_DZWz30Q9CVtspvsbnwRPVqLYJFi4d7CfgV7HLnzcn3wv3cmX-dp60MCIQNJZmdnZ3Ymvx_AG2e9LYJA47UBExQMmWNtMecJKjOWF4qYMqnb4kyeXmRfZvms781p-rbKwSe2jtovHe2RH2GonNBiwj-sfsZEGkXF1Z5B4zbsE3IZ5V5qpraYu4nuIDNpN67gyYDZKPRRMz-0c3coJdowMav8sSbdW5kG1VN1vBbXBZ7_9k_-VURt16aTB3C_DyrZx84KHsKtUD-CO1_7svljOP9sFguK8kLDTO0ZBn2MesrZsmLUHGvWv9iGfpdijoxg_Z4ZthqZvWJa6TxrgWjZZc1ayu0ncHFy_H16GvdkCrHLNd_EeU5UkbJKlcmN81wG7U1V5UZYjYf3mJlZ7h1XQWbeYSKDV-QCQsCcqkjFU9ir8T2fA5OqSKvUOa-4Rz8rbBKMdtwqUwiCN4wgHtRZuh5pnAgvFmVb8Ra6bOYlqr_s1R_B21F-1WFs3Cg52RmdrXiBcazkWQQHw3CV_WRsytF0Ing93sVZRKURU4flFYqgb5KJEDdLSJ1nmNrpCJ51g799tu5QdCJQO2YxChCC9-6d-vJHi-TNhcSYEz_r3WBA27e-XgMv_vuBB3C33XumdhvxEvY266vwCoOmjZ20UwPPeppOYP_T8dm3c7yayulvTOsatw
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIgESQrwxhXYPILi4dXbt9RoJIVQoKX0cUCv15u7LolHkhDgV6o_iPzLjVwi03HrIIfIoseex-83OeD6AV9Y4k3mBzms8JigImUNlMOfxaawNz1JiyqRui0M5PI6_niQnK_CrexeG2iq7NbFeqN3E0hn5FkLliDYT_mH6IyTSKCqudgwajVfs-YufmLFV73c_oXlfc77z-Wh7GLakAqFNFJ-HSUKUibIYpDrR1nHpldNFkWhhFH6cwwzFcGd56mXsLAJ6_Eah4D3mFtlA4O_egJuxECmN6lfbi46SLFLNiE46_ct41M2IFGqrGm2akd2UEmOGmFz-2APvTnWF5igaHo3LgO6__Zp_FW3rvXDnPtxrQSz72HjdA1jx5UO4ddCW6R_Bty96PCZU6SumS8cQZDLqYWeTglEzrp5dsDm9nsUsOd3sHdNs2jOJhbSzOlYPvmVnJaspvh_D8bXo-Qmslnifz4DJNBsUA2tdyh2u68JEXivLTaozQeMUAwg7dea2nWxOBBvjvK6wC5VXoxzVn7fqD-BNLz9tZnpcKbm-ZJ2FeIa4WfI4gLXOXHkb_FXeu2oAG_1VjFoqxejST85RBNdCGQlxtYRUSYyppArgaWP8xX-rZmpPAOmSW_QCNDF8-Up59r2eHM6FRIyLj_W2c6DFXV-ugef_fcANuD08OtjP93cP99bgTn3uTa0-4gWszmfn_iUCtrlZr8OEwel1x-VvgPtUqg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIlVICPHGLbR7AMHFTbIb766REEKU0FKoEKJSbu6-LBpFThqnQv1p_Dtm_EgItNx6yCHyKLHnPTvj-QCeO-ttGgQqrw1YoGDKHGuLNU9QfWN5qggpk6YtjuT-cf_TMBmuwa_2XRgaq2x9YuWo_cTRGXkHU-UuBRPeyZupiK97g7fTs5gApKjR2qJp1BpyGC5-YvVWvjnYQ1G_4Hzw4fv7_bgBGIhdovk8ThKCT5R5T5nEOM9l0N7keWKE1fjxHqsVy73jKsi-d5jc4zcyixCwzkh7An_3BtxUAqMmmpIaquW-366u13XSSWDKu-2-SKE75WjXjtyulGg_hOryRzy8PTUliiavMTUuS3r_nd38q4FbxcXBXbjTJLTsXa2B92AtFPdh40vTsn8A3z6a8ZgyzFAyU3iGCSejeXY2yRkN5prZBZvTq1rMkQLOXjPDpgtUsZiirGfVElx2WrAK7vshHF8Lnx_BeoH3-QSYVGkv7znnFffo44XtBqMdt8qkglYrRhC37Mxcs-WcwDbGWdVtFzorRxmyP2vYH8HLBf203u9xJeX2inSW5Cnm0JL3I9hqxZU1jqDMFmobwc7iKlowtWVMESbnSIJ-UXaFuJpC6qSPZaWO4HEt_OV_63qDTwRqRS0WBLQ9fPVKcfqj2iLOhcR8Fx_rVatAy7u-nAOb_33AHdhAi8w-HxwdbsGt6gicpn7EU1ifz87DM8zd5na7shIGJ9dtlr8BkbhZDA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gallstones+and+the+risk+of+biliary+tract+cancer%3A+a+population-based+study+in+China&rft.jtitle=British+journal+of+cancer&rft.au=Hsing%2C+A+W&rft.au=Gao%2C+Y-T&rft.au=Han%2C+T-Q&rft.au=Rashid%2C+A&rft.date=2007-12-03&rft.issn=0007-0920&rft.volume=97&rft.issue=11&rft.spage=1577&rft.epage=1582&rft_id=info:doi/10.1038%2Fsj.bjc.6604047&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-0920&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-0920&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-0920&client=summon